Cardiol Therapeutics Inc. CRDL
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -24.69M | -26.33M | -24.22M | -24.89M | -26.99M |
| Total Depreciation and Amortization | 65.00K | 75.10K | 73.00K | 89.00K | 217.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.46M | 9.04M | 7.62M | 6.87M | 9.68M |
| Change in Net Operating Assets | -256.00K | -332.10K | -524.70K | 635.20K | -872.90K |
| Cash from Operations | -17.42M | -17.55M | -17.05M | -17.30M | -17.97M |
| Capital Expenditure | -41.30K | -43.80K | -17.40K | -19.60K | -23.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -41.30K | -43.80K | -17.40K | -19.60K | -23.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -55.20K | -55.20K | -55.20K | -55.20K | -46.00K |
| Issuance of Common Stock | 33.38M | 30.92M | 16.07M | 21.39M | 21.39M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.71M | -1.71M | -477.00K | -2.65M | -2.65M |
| Cash from Financing | 22.85M | 21.07M | 11.15M | 13.35M | 13.35M |
| Foreign Exchange rate Adjustments | 279.90K | -351.80K | -588.70K | 933.30K | 405.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.66M | 3.13M | -6.51M | -3.04M | -4.23M |